Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-176986
Filing Date
2025-08-08
Accepted
2025-08-08 16:06:43
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 d66414ds3.htm S-3 349349
2 EX-5.1 d66414dex51.htm EX-5.1 26043
3 EX-23.1 d66414dex231.htm EX-23.1 1592
4 EX-23.2 d66414dex232.htm EX-23.2 1791
5 EX-FILING FEES d66414dexfilingfees.htm   iXBRL EX-FILING FEES 35690
6 GRAPHIC g66414g02v02.jpg GRAPHIC 76901
7 GRAPHIC g66414g0806145341120.jpg GRAPHIC 2406
  Complete submission text file 0001193125-25-176986.txt   691396

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT d66414dexfilingfees_htm.xml XML 16116
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289424 | Film No.: 251198428
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)